Cancer Immunology Research

Papers
(The H4-Index of Cancer Immunology Research is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Abstract P039: The immune profile of colorectal and pancreas adenocarcinomas: Differences between central and peripheric tumor regions192
Abstract P003: Efficacy results of a novel vaccine composed of stimulated and haptenized tumors cells in Balbc mice grafted with murine colon adenocarcinoma CT26 cells131
A Sampling of Highlights from the Literature124
Exercise as an Immune Boost: Mechanism-Driven Support for Lifestyle Interventions109
Optimal Neoantigen Cancer Vaccines Target CD8+ and CD4+ T Cells with Multiple Antigens94
Transforming the Dark into Light: A Siglec-9 Switch88
IL18 at the Crossroads between Chronic Inflammation and T-cell Exhaustion in Pancreatic Cancer83
IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal Adenocarcinoma80
Combination Therapy Approaches to Enhance the Efficacy of ERV-Targeting Vaccines in Cancer69
Self-Renewing CD8+ T-cell Abundance in Blood Associates with Response to Immunotherapy67
T-cell Senescence in the Tumor Microenvironment65
Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment65
Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer64
A Population of TIM4+FOLR2+ Macrophages Localized in Tertiary Lymphoid Structures Correlates to an Active Immune Infiltrate Across Several Cancer Types61
Host Interactions with Engineered T-cell Micropharmacies59
Reciprocal Interactions Between the Gut Microbiome and Mammary Tissue Mast Cells Promote Metastatic Dissemination of HR+ Breast Tumors57
CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity56
Preclinical Characterization and Phase I Study of an Anti–HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ Malignancies56
The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions55
Profiling Multiple CD8+ T-cell Functional Dimensions Enhances Breast Cancer Immune Assessment54
Abstract P073: Gut microbiota shift in melanoma patients undergoing immunotherapy is associated with clinical response53
Abstract P009: Correlation between immune modulation of macrophage recruitment and new blood vessel formation in a subcutaneous murine mouse model of colorectal cancer53
Abstract IA17: The power of ONE: Immunology in the age of single cell genomics52
A Sampling of Highlights from the Literature52
High Mobility Group Protein B1 Decreases Surface Localization of PD-1 to Augment T-cell Activation47
Loss of LRRC33-Dependent TGFβ1 Activation Enhances Antitumor Immunity and Checkpoint Blockade Therapy45
Cannabidiol Enhances Atezolizumab Efficacy by Upregulating PD-L1 Expression via the cGAS–STING Pathway in Triple-Negative Breast Cancer Cells43
Ncoa2 Promotes CD8+ T cell–Mediated Antitumor Immunity by Stimulating T-cell Activation via Upregulation of PGC-1α Critical for Mitochondrial Function42
Evaluation of proton minibeam radiation therapy on anti-tumor immune responses in a rat model of glioblastoma42
The HSP90 Inhibitor Pimitespib Targets Regulatory T Cells in the Tumor Microenvironment41
High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects41
A Sampling of Highlights from the Literature41
Harnessing Microbiota to Improve Immunotherapy for Gastrointestinal Cancers40
Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer39
Engineering CD20 CARs with a Twist39
Ethnicity, Immunity, and Outcomes: Biology versus Socioeconomic Status39
Neoadjuvant STING Activation, Extended Half-life IL2, and Checkpoint Blockade Promote Metastasis Clearance via Sustained NK-cell Activation37
SPP1+ Tumor-associated Macrophages Drive Immunotherapy Resistance via CD8+ T-Cell Dysfunction in Clear Cell Renal Cell Carcinoma37
Age-Associated Contraction of Tumor-Specific T Cells Impairs Antitumor Immunity37
0.17096090316772